Anti-inflammatory peptides derived from c-reactive protein
CA 2244730 A1 · Owner: Yeda Research And Development Co. Ltd. · Inventors: Fridkin, Matityahu; Yavin, Eran J.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A peptide corresponding to positions 89-96 of the sequence of human C-reactive protein (CRP) of the formula: Val89-Thr-Val-Ala-Pro-Val-His-Ile96 and modifications thereof obtained by substitution elongattion, amidation of the , C-terminal or acylation of the N-terminal inhibit in vitro the enzymatic , activity of human leukocyte elastase (hLE) and/or of human leukocyte cathepsin G(hCG) and can be used for the treatment of chronic inflammation conditions such as rheumatoid arthritis, pulmonary emphysema and cystic fibrosis.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 27, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended January 27, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 27, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.